Back to SGP

Vestal Point Capital, LP → SGP

Vestal Point Capital, LP SGP Position History

SpyGlass Pharma, Inc. • Healthcare

Quarters held
3
Latest value
$16.6M
Q3 2026
Peak value
$17.3M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$17.3M
Q2 2026$14.9M
Q3 2026$16.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$16.6M640.0K——
Q2 2026$14.9M670.0K——
Q1 2026$17.3M666.8K——

Other funds holding SGP

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M
Vestal Point Capital, LP SGP Holdings: 13F Position History | Track13F